Financial Results and Business Update for the Second Quarter Ended Sept. 30, 2023 November 13, 2023 Speakers Matthew Richard Frank Eric Venker, MD, Mayukh Gline Pulik Torti, MD PharmD Sukhatme, MD Chief Chief Vant Chair President and President and Executive Officer Financial Officer Chief Operating Chief Investment Officer Officer 2 For investor audiences only Forward-Looking Statements Forward–Looking Statements subject to certain risks and uncertainties that could cause actual results to differ materially ...